$YORW

Meet Wall Street's Greatest Dividend Stock: A Company Paying Dividends for Over 200 Years That 99% of Investors Have No Clue Exists

York Water (YORW), a small-cap water utility, has paid dividends continuously for 210 years, the longest streak on Wall Street. It operates as a regulated monopoly in Pennsylvania, with predictable cash flow and recent rate increases boosting revenue. The stock has a $503M market cap and trades 141,500 shares daily. According to Hartford Funds and Ned Davis Research, dividend payers outperformed non-payers 9.2% to 4.21% annually from 1973-2025.

Original reporting
Published Sep 30, 2026, 11:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 12:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Meet Wall Street's Greatest Dividend Stock: A Company Paying Dividends for Over 200 Years That 99% of Investors Have No Clue Exists — source image
Decision brief

The 30-second read

$YORWBullishMed
01

Why it matters

The newly approved rate hike adds $18.85 M to revenue, reinforcing its dividend reliability and potentially lifting the stock.

02

Market read

A fresh regulatory win for a dividend‑centric micro‑cap could attract income investors and modest price appreciation.

03

What to watch

Low trading volume and small market cap may cause price volatility despite the positive news.

Relevance 6/10Novelty 6/10Timing: today's release

Background

York Water (YORW) is a small‑cap water and wastewater utility with a 210‑year dividend streak.

Company-level read

Ticker impact

$YORWBullishHigh confidence
Context

Pennsylvania PPUC approved a rate‑hike request boosting York Water's annual revenue by $18.85 million (≈24%).

Expected impact

likely upward pressure as investors price in higher cash flow

Evidence & confidence

The approved rate hike is a fresh, material catalyst for a dividend‑focused utility.

Market effects

Highlights the stability and rate‑adjustment potential of regulated water utilities.

May boost sentiment toward Pennsylvania‑based utilities.

Limited; primarily a micro‑cap US utility story.

Counterpoint

Higher rates could strain customers and invite political pushback, limiting upside.

Key entities

  • York Water

    US‑listed water utility (NASDAQ:YORW).

  • Pennsylvania Public Utility Commission

    Approved the rate increase.

Related articles

$YORWLow

THE YORK WATER COMPANY REPORTS 2nd QUARTER AND SIX MONTHS EARNINGS

YORK WATER CO (YORW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 NEWS RELEASE Contact Information: JT Hand, President & CEO jth@yorkwater.com -OR- Matthew E. Poff, Chief Financial Officer matthewp@yorkwater.com 717-845-3601 130 East Market Street York, PA 17401 FOR IMMEDIATE RELEASE THE YORK WATER COMPANY REPORTS 2 nd QUARTER AND

$VIRMedAI 8/10

Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer

Vir Biotechnology, Inc. (VIR) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Vir Biotechnology Announces PSMA-targeted PRO-XTEN ® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer SAN FRANCISCO, Calif. October 6, 2026 - Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.

$SRRKMedAI 8/10

Scholar Rock resubmits EU application for SMA treatment

Scholar Rock (NASDAQ:SRRK) resubmitted its EU application for apitegromab, a treatment for spinal muscular atrophy, using an alternate fill-finish facility. The company withdrew its previous application due to GMP compliance issues. Scholar Rock anticipates a CHMP opinion in the first half of 2027. Apitegromab is FDA-approved in the U.S. under the brand name ISEMBYLD.